Extrawell Pharmaceutical Holdings (HKSE:00858) Inventory Turnover : 2.35 (As of Mar. 2024)

View and export this data going back to 1999. Start your Free Trial

What is Extrawell Pharmaceutical Holdings Inventory Turnover?

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Extrawell Pharmaceutical Holdings's Cost of Goods Sold for the six months ended in Mar. 2024 was HK$15.07 Mil. Extrawell Pharmaceutical Holdings's Average Total Inventories for the quarter that ended in Mar. 2024 was HK$6.41 Mil. Extrawell Pharmaceutical Holdings's Inventory Turnover for the quarter that ended in Mar. 2024 was 2.35.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Extrawell Pharmaceutical Holdings's Days Inventory for the six months ended in Mar. 2024 was 77.69.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Extrawell Pharmaceutical Holdings's Inventory-to-Revenue for the quarter that ended in Mar. 2024 was 0.22.

Extrawell Pharmaceutical Holdings Inventory Turnover Historical Data

The historical data trend for Extrawell Pharmaceutical Holdings's Inventory Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Extrawell Pharmaceutical Holdings Inventory Turnover Chart

Extrawell Pharmaceutical Holdings Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Inventory Turnover

Get a 7-Day Free Trial

5.93

5.40

4.54

7.22

5.90

Extrawell Pharmaceutical Holdings Semi-Annual Data
	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
Inventory Turnover	Get a 7-Day Free Trial															2.21	3.27	5.85	3.55	2.35

Extrawell Pharmaceutical Holdings Inventory Turnover Calculation

Extrawell Pharmaceutical Holdings's Inventory Turnover for the fiscal year that ended in Mar. 2024 is calculated as

	Inventory Turnover (A: Mar. 2024 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (A: Mar. 2024 )	/ (	(Total Inventories (A: Mar. 2023 )	+	Total Inventories (A: Mar. 2024 ))	/	count )
=	30.319	/ (	(3.018	+	7.265)	/	2 )
=	30.319	/	5.1415
=	5.90

Extrawell Pharmaceutical Holdings's Inventory Turnover for the quarter that ended in Mar. 2024 is calculated as

	Inventory Turnover (Q: Mar. 2024 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (Q: Mar. 2024 )	/ (	(Total Inventories (Q: Sep. 2023 )	+	Total Inventories (Q: Mar. 2024 ))	/	count )
=	15.069	/ (	(5.564	+	7.265)	/	2 )
=	15.069	/	6.4145
=	2.35

Extrawell Pharmaceutical Holdings (HKSE:00858) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Extrawell Pharmaceutical Holdings's Days Inventory for the six months ended in Mar. 2024 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Mar. 2024 )	/	Cost of Goods Sold (Q: Mar. 2024 )	*	Days in Period
	=	6.4145	/	15.069	*	365 / 2
	=	77.69

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Extrawell Pharmaceutical Holdings's Inventory to Revenue for the quarter that ended in Mar. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	6.4145	/	28.957
	=	0.22

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

Extrawell Pharmaceutical Holdings Inventory Turnover Related Terms

Thank you for viewing the detailed overview of Extrawell Pharmaceutical Holdings's Inventory Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Extrawell Pharmaceutical Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Extrawell Pharmaceutical Holdings Ltd (HKSE:00858) » Definitions » Inventory Turnover

Traded in Other Exchanges

N/A

Address

979 King’s Road, Suites 2206-08, 22nd Floor, Devon House, Taikoo Place, Quarry Bay, Hong Kong, HKG

Website

http://www.extrawell.com.hk

Extrawell Pharmaceutical Holdings Ltd is an investment holding company. The company's operating segment includes Manufacturing; Trading and Gene Development. It generates maximum revenue from the Manufacturing segment. The manufacturing segment is engaged in the development, manufacture, and sales of pharmaceutical products. Its trading segment is engaged in the marketing and distribution of imported pharmaceutical products. The gene development segment is engaged in the commercial exploitation and development of genome-related technology. Geographically, it derives a majority of its revenue from China.

Executives

Mao Yumin	2201 Interest of corporation controlled by you
Biowindow Gene Development (hong Kong) Limited	2201 Interest of corporation controlled by you
Ease Gold Investments Limited	2201 Interest of corporation controlled by you
Jnj Investments Ltd	2201 Interest of corporation controlled by you
United Gene Group Ltd	2201 Interest of corporation controlled by you
United Gene Holdings Limited	2201 Interest of corporation controlled by you
United Gene International Holdings Group Limited	2101 Beneficial owner
Xie Yi	2201 Interest of corporation controlled by you
Huang Zhenping	2101 Beneficial owner
United Gene Industry Group Limited	2101 Beneficial owner
Chen Xuhua	2202 Interest of your spouse
Cheng Yong	2201 Interest of corporation controlled by you

Extrawell Pharmaceutical Holdings Headlines

No Headlines